7 Jul 2021 11:29
Ap24
Â
FORMÂ 38.5(a)
Â
IRISHÂ TAKEOVERÂ PANEL
Â
DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
Â
DEALINGSÂ BYÂ CONNECTEDÂ EXEMPTÂ PRINCIPALÂ TRADERSÂ WITHÂ RECOGNISEDÂ INTERMEDIARYÂ STATUSÂ ANDÂ DEALINGÂ INÂ AÂ CLIENT-SERVINGÂ CAPACITY
Â
1. KEYÂ INFORMATION
Â
Name of exempt principal trader | J.P. Morgan Securities Plc |
Company dealt in | UDG Healthcare Plc |
Class of relevant security to which the dealings being disclosed relate (Note 1) | €0.05 ordinary shares |
Date of dealing | 6 July 2021 |
Â
2. DEALINGS (Note 2)
Â
(a) Purchases and sales
Â
Total number of relevant securities acquired | Highest price paid (Note 3) | Lowest price paid (Note 3) |
258,799 868 (Loan Return)* | 10.7109 GBP N/A | 10.6900 GBP N/A |
Â
Â
Total number of securities disposed | Highest price received (Note 3) | Lowest price received (Note 3) |
1,039,999 | 10.7150 GBP | 10.6899 GBP |
Â
Â
(b) Derivatives transactions (other than options transactions)
Â
Product name, e.g. CFD | Nature of transaction (Note 4) | Number of relevant securities (Note 5) | Price per unit (Note 3) |
Equity Swap | Decrease Long   Decrease Short             Increase Long     Increase Short            Opening a Long Position   Opening a Short Position | 581 331  1,585 1,669 161,951 742 11,836 351 284 388 16,584 296 20,000 49,431  3,128 7 24,436 2,180  4,324 372 1,785 57,873 1,710 4,779 2,671 296 126,777 46,897 12,407  720,000 1,208  302 | 10.7029 GBP 10.7102 GBP  10.6900 GBP 10.6976 GBP 10.6991 GBP 10.6994 GBP 10.7041 GBP 10.7047 GBP 10.7072 GBP 10.7081 GBP 10.7095 GBP 10.7097 GBP 10.7098 GBP 10.7100 GBP  10.6899 GBP 10.6992 GBP 10.7024 GBP 10.7105 GBP  10.6909 GBP 10.6943 GBP 10.6952 GBP 10.6996 GBP 10.7001 GBP 10.7005 GBP 10.7029 GBP 10.7053 GBP 10.7084 GBP 10.7101 GBP 10.7109 GBP  10.7000 EUR 10.7097 GBP  10.7102 GBP |
Â
Ap25
Â
(c) Options transactions in respect of existing relevant securities
Â
Â
(i) Writing, selling, purchasing or varying
Â
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 5) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 3) |
 |  |  |  |  |  |  |
Â
Â
(ii) Exercising
Â
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 3) |
 |  |  |
Â
Â
3. Â OTHERÂ INFORMATION
Â
Agreements, arrangements or understandings relating to options or derivatives
Â
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to theÂ
voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisitionÂ
or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
Â
Â
Â
Â
Â
Â
Date of disclosure | 7 July 2021 |
Contact name | Alwyn Basch |
Telephone number | 020 7742 7407 |
Name of offeree/offeror with which connected | UDG Healthcare Plc |
Nature of connection (Note 6) | Financial adviser to CD&R Fund XI |
Â
Follow the stocks